4 month Schedule point

Australia’s active vaccine safety system

National Immunisation Program Schedule vaccines

Individuals are given three vaccinations at the 4 month National Immunisation Program Schedule point:

Infanrix hexa protects against diphtheria, tetanus, whooping cough, hepatitis B, Haemophilus influenzae type b and polio
Rotarix protects against rotavirus
Prevenar 13 protects against pneumococcal disease

AusVaxSafety has been conducting surveillance of the vaccines given at the 4 month Schedule point on a continuous basis since 2019. The analysis has remained constant over this time and not identified any safety concerns.

The latest medical attendance rate for the 4 month Schedule point is below and will be updated on a quarterly basis.

More detailed safety data from the 4 month Schedule point is available from the 2020 Vaccine Safety in Australia AusVaxSafety Summary Report below.

Click here to download AusVaxSafety data from the 4 month schedule point for 2020

Last updated December 2021

National Immunisation Program Schedule vaccines

Do COVID boosters cause more or fewer side effects? How quickly does protection wane? Your questions answered

AusVaxSafety receives funding
from the Australian Government

NCIRS, Kids Research, Sydney Children’s Hospitals Network, Cnr Hawkesbury Rd & Hainsworth St, Westmead Locked Bag 4001, Westmead NSW 2145 Tel (612) 9845 1433 | Fax (612) 9845 1418 | ABN 53 188 579 090

We acknowledge that the National Centre for Immunisation Research and Surveillance (NCIRS) is on the land of the traditional owners the Aboriginal and Torres Strait Islander peoples, the First Australians, and recognise their culture, history, diversity and their deep connection to the land. Together, through research and partnership, we aim to move to a place of equity for all. NCIRS also acknowledges and pays respect to other Aboriginal and Torres Strait Islander nations from which our research, staff and community are drawn.

Our website meets the criteria for credibility and content as defined by the Global Advisory Committee on Vaccine Safety.

We acknowledge that the National Centre for Immunisation Research & Surveillance (NCIRS) is on the land of the traditional owners the Aboriginal and Torres Strait Islander peoples, the First Australians, and recognise their culture, history, diversity and their deep connection to the land. Together, through research and partnership, we aim to move to a place of equity for all. NCIRS also acknowledges and pays respect to other Aboriginal and Torres Strait Islander nations from which our research, staff and community are drawn.

National Immunisation Program Schedule vaccines

National Immunisation Program Schedule vaccines

News & events

AusVaxSafety commences routine monitoring of 2022 seasonal influenza vaccines

Children experience fewer side effects from COVID-19 vaccine

AusVaxSafety actively monitoring Novavax COVID-19 vaccine safety

Do COVID boosters cause more or fewer side effects? How quickly does protection wane? Your questions answered

Subscribe to our newsletter for immunisation professionals

Subscribe to our newsletter for immunisation professionals